Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€60.00

€60.00

-3.230%
-2.0
-3.230%
€59.20

€59.20

 
30.07.26 / Stuttgart Stock Exchange WKN: A2AHZS / Symbol: NGVT / Name: Ingevity / Stock / Chemicals / Mid Cap /
Latest predictions
07.07.26
-6.98%
buy
21.06.26
-5.51%
buy
01.03.26
-0.25%
buy
26.02.26
1.95%
buy
€60.10
10.12.25
31.18%
buy
€58.30
05.09.25
19.61%
buy
Best running prediction
€53.17
07.08.25
49.22%
buy
Your prediction

Ingevity Corp Stock

Heavy losses for Ingevity Corp today as the stock fell by -€2.000 (-3.230%).
With 7 Buy predictions and not the single Sell prediction the community is currently very high on Ingevity Corp.
On the other hand, the target price of 59 € is below the current price of 60.0 € for Ingevity Corp, so the potential is actually -1.67%.

Pros and Cons of Ingevity Corp in the next few years

Pros
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
S********** s********
Cons
?
M***** P*******
?
C******** o* t** e**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Ingevity Corp vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Ingevity Corp -3.230% -4.651% -6.107% 65.679% 23.098% 5.128% -
PTT Global Chemical -fgn- -5.240% -16.204% 8.383% 49.587% 69.159% -11.275% -37.153%
Barito Pacific Tbk PT 1.970% -6.748% 26.667% -41.538% -51.282% 141.270% 80.952%
Braskem Pfd ADR 6.670% -9.722% -8.879% -28.832% -19.421% -78.571% -89.948%

Comments

Ingevity (NGVT) was upgraded by Wall Street Zen from "buy" to "strong-buy".
Ratings data for NGVT provided by MarketBeat
Show more

Ingevity (NGVT) was upgraded by Wall Street Zen from "buy" to "strong-buy".
Ratings data for NGVT provided by MarketBeat
Show more

Ingevity (NGVT) was upgraded by Wall Street Zen from "buy" to "strong-buy".
Ratings data for NGVT provided by MarketBeat
Show more

News

Ingevity Q1 Earnings Call HighlightsPhoto, wide shot, wide-angle lens, soft focus,  Quarry, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Sebastião Salgado: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-YQuR80w6IvxjemEoWYDXbEZo.png?st=2023-10-15T10%3A03%3A37Z&se=2023-10-15T12%3A03%3A37Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-10-14T14%3A03%3A01Z&ske=2023-10-15T14%3A03%3A01Z&sks=b&skv=2021-08-06&sig=/3q45HS%2B7KQiNIRh0W63diwmt7u%2BeQQMkMTkhvmYMtE%3D
Ingevity Q1 Earnings Call Highlights

Ingevity (NYSE:NGVT) reported higher first-quarter 2026 sales and reaffirmed its full-year outlook as management highlighted progress on portfolio simplification, strong margins in its Performance

Investor Builds $6 Million Position in Surging Chemicals Name Beating the S&P 500 by Nearly 40 PointsPhoto, wide shot, wide-angle lens, soft focus,  Quarry, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Sebastião Salgado: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-YQuR80w6IvxjemEoWYDXbEZo.png?st=2023-10-15T10%3A03%3A37Z&se=2023-10-15T12%3A03%3A37Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-10-14T14%3A03%3A01Z&ske=2023-10-15T14%3A03%3A01Z&sks=b&skv=2021-08-06&sig=/3q45HS%2B7KQiNIRh0W63diwmt7u%2BeQQMkMTkhvmYMtE%3D
Investor Builds $6 Million Position in Surging Chemicals Name Beating the S&P 500 by Nearly 40 Points

On February 17, 2026, EVR Research disclosed a new position in Ingevity (NYSE:NGVT), acquiring 100,000 shares worth $5.92 million.

In a U.S. Securities and Exchange Commission (SEC) filing dated